ENPP2 and breast angiosarcoma: Overall, decreased methylation levels of the ATX promoter were detected in advanced BA patients with fibrosis, persistent jaundice, and late stage hepatic dysfunction as compared with those in early stage (P = 0.0003, P = 0.0077, and P = 0.023, respectively) (Fig 2B–2D).